These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28723575)

  • 1. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
    Bak RO; Porteus MH
    Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex.
    de Alencastro G; Puzzo F; Pavel-Dinu M; Zhang F; Pillay S; Majzoub K; Tiffany M; Jang H; Sheikali A; Cromer MK; Meetei R; Carette JE; Porteus MH; Pekrun K; Kay MA
    Mol Ther; 2021 Mar; 29(3):1016-1027. PubMed ID: 33678249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular generation of single-strand template increases the knock-in efficiency by combining CRISPR/Cas9 with AAV.
    Xiao Q; Min T; Ma S; Hu L; Chen H; Lu D
    Mol Genet Genomics; 2018 Aug; 293(4):1051-1060. PubMed ID: 29671068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
    Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
    Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard screening methods underreport AAV-mediated transduction and gene editing.
    Lang JF; Toulmin SA; Brida KL; Eisenlohr LC; Davidson BL
    Nat Commun; 2019 Jul; 10(1):3415. PubMed ID: 31363095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain.
    Nishiyama J; Mikuni T; Yasuda R
    Neuron; 2017 Nov; 96(4):755-768.e5. PubMed ID: 29056297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV Vectorization of DSB-mediated Gene Editing Technologies.
    Moser RJ; Hirsch ML
    Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
    Dudek AM; Porteus MH
    Front Immunol; 2021; 12():660302. PubMed ID: 34122418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy.
    Wang Y; Jiang H; Li M; Xu Z; Xu H; Chen Y; Chen K; Zheng W; Lin W; Liu Z; Lin Z; Zhang M
    Gene; 2024 Nov; 927():148733. PubMed ID: 38945310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
    Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
    CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of AAV vector integration into CRISPR-induced DNA breaks.
    Hanlon KS; Kleinstiver BP; Garcia SP; Zaborowski MP; Volak A; Spirig SE; Muller A; Sousa AA; Tsai SQ; Bengtsson NE; Lööv C; Ingelsson M; Chamberlain JS; Corey DP; Aryee MJ; Joung JK; Breakefield XO; Maguire CA; György B
    Nat Commun; 2019 Sep; 10(1):4439. PubMed ID: 31570731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Systems Suitable for Single AAV Vector Delivery.
    Stevanovic M; Piotter E; McClements ME; MacLaren RE
    Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.
    Chupradit K; Thongsin N; Tayapiwatana C; Wattanapanitch M
    PLoS One; 2022; 17(7):e0270963. PubMed ID: 35797389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.